KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Edwards Lifesciences (EW) Shares Issued (2016 - 2025)

Edwards Lifesciences (EW) has 17 years of Shares Issued data on record, last reported at $32.3 million in Q4 2025.

  • For Q4 2025, Shares Issued rose 12.94% year-over-year to $32.3 million; the TTM value through Dec 2025 reached $174.1 million, down 3.01%, while the annual FY2025 figure was $174.1 million, 3.01% down from the prior year.
  • Shares Issued reached $32.3 million in Q4 2025 per EW's latest filing, down from $34.7 million in the prior quarter.
  • Across five years, Shares Issued topped out at $62.1 million in Q1 2024 and bottomed at $27.5 million in Q4 2022.
  • Average Shares Issued over 5 years is $41.4 million, with a median of $36.1 million recorded in 2022.
  • Peak YoY movement for Shares Issued: surged 48.21% in 2024, then fell 19.65% in 2025.
  • A 5-year view of Shares Issued shows it stood at $33.9 million in 2021, then dropped by 18.88% to $27.5 million in 2022, then rose by 20.73% to $33.2 million in 2023, then fell by 13.86% to $28.6 million in 2024, then increased by 12.94% to $32.3 million in 2025.
  • Per Business Quant database, its latest 3 readings for Shares Issued were $32.3 million in Q4 2025, $34.7 million in Q3 2025, and $57.2 million in Q2 2025.